RADx Issues $77.7M in New Contracts for SARS-CoV-2 Rapid Diagnostic Tests

Share:

EmailFacebookLinkedInXWhatsAppShare
NIBIB in the News
October 14, 2021

The National Institutes of Health's Rapid Acceleration of Diagnostics initiative announced on Thursday that it has awarded $77.7 million to develop and manufacture 12 new rapid diagnostic tests for SARS-CoV-2.  Source: Genomeweb.